Health experts at the European level have recommended this Wednesday that, for the moment, the use of third doses be limited to people with severely weakened immune systems, such as transplant patients or patients with cancer treatments. Both the European Center for Disease Prevention and Control (ECDC) and the Spanish vaccine presentation have reached the same conclusion: apply a third dose to immunosuppressed people and not to the general population.
“Based on current evidence, there is no urgent need to administer booster doses of vaccines to fully vaccinated individuals in the general population. The report also notes that additional doses should be considered for people with severely weakened immune systems if they fail to achieve a level adequate protection of standard vaccination “, has reported the ECDC in a statement.
During the press conference after the meeting of the Interterritorial Council, the Minister of Health, Carolina Darias, referred to the resolution of the European body, highlighting that the vaccine presentation had reached the same conclusion during its meeting this morning.
“This morning the presentation of vaccines has met and has made a proposal that proposes the recommendation to administer an additional dose, which would be a dose that is given to those people to complete a vaccination schedule so that they acquire at least the same level of response immune than other people “, the minister wanted to differentiate in this way between booster doses to the general population and additional doses to immunosuppressed people. “We are referring to some categories of people with some type of immunosuppression, such as, for example, solid transplant recipients,” he exemplified.
“The EMA and the ECDC coincide as well. They say, first of all, that there is no urgent need to administer third doses or booster, this would be booster doses, not the extra dose category that I mentioned above. It establishes the convenience of administering an additional dose to immunocompromised people to strengthen their immune response. This proposal of the vaccine presentation coincides with what the EMA and the ECDC have just communicated and will be submitted to the consideration of the Public Health commission next week, “he added. Therefore, no response will be adopted. less until next week. “As you can see, it seems that the path is opening up,” he concluded.